Medicaloid

Bristol Myers Squibb

Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China

Medicaloid
For existing PD-1/L1 inhibitors, China represents an opportunity for new growth. But foreign drugmakers have once again lost their chance to reach a wider pool...

Novavax and Commonwealth of Australia announce agreement in principle for acquisition of Novavax COVID-19 vaccine

Medicaloid
Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the signing of a non-binding Heads of Terms...